The largest database of trusted experimental protocols

4 protocols using cp c cp 94251

1

Oesophageal Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six cell lines were acquired for these experiments. Human oesophageal cell line HET-1A (ATCC® CRL-2692™) was used for the healthy control. The Barrett’s oesophagus in vitro model comprised of one non-dysplastic cell line and three high-grade dysplastic cell lines: CP-A/KR-42421 (ATCC® CRL-4027™), CP-B/ CP-52731 (ATCC® CRL-4028™), CP-C/CP-94251 (ATCC® CRL-4029™) and CP-D/CP-18821 (ATCC® CRL-4030™), respectively. The cell line OE19/JROECL19 (ECACC 96071721) was used as a representative for oesophageal adenocarcinoma. All cell lines were authenticated and confirmed negative for mycoplasma infection.
+ Open protocol
+ Expand
2

BALB/C Nude Mice Esophageal Cancer Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of SPF-graded 30 BALB/C nude mice (Vital River Laboratories, SCXK (Shanghai) 2017–0011), aged 6–8 weeks and weighing 16–19 g, were housed for 7 days with humidity of 60–80% at temperature of 22 ± 2°C, with freedom to eat and drink, in the condition of light exposure and avoidance alternately for 12 h, respectively. All animal experiments were conducted under the approval of Ethics Committee of our hospital and in accordance to the Guide for the Care and Use of Laboratory Animal. Extensive efforts were made to ensure minimal suffering of the animals included in the study. Human esophageal cancer cell CP-C (CP-94251) was purchased from ATCC and the item number was ATCCCRL-4029.
+ Open protocol
+ Expand
3

Cell Culture Protocols for CP and EPC2-hTert Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
We cultured CP-A (KR-42421), CP-B (CP-52731), and CP-C (CP-94251) cells (American Type Culture Collection, Manassas, VA) in MCDB-153 medium (cat. no. M7403; Sigma-Aldrich, St. Louis, MO) supplemented with 0.4 μg/mL hydrocortisone, 20 ng/mL recombinant human epidermal growth factor (cat. no. E9644; Sigma-Aldrich), 8.4 μg/L cholera toxin (cat. no. H0135; Sigma-Aldrich), 20 mg/L adenine (cat. no. A2786; Sigma-Aldrich), 140 μg/mL bovine pituitary extract (cat. no. P1476; Sigma-Aldrich), ITS supplement (cat. no. I1884; Sigma-Aldrich) (final concentrations: 5 μg/mL insulin, 5 μg/mL transferrin, 5 ng/mL sodium selenite), 4 mM glutamine, and 5% fetal bovine serum. EPC2-hTert cells20 (link) were cultured in Keratinocyte-SFM medium (GIBCO/Life Technologies, Grand Island, NY) supplemented with bovine pituitary extract and recombinant human epidermal growth factor (GIBCO). Soybean trypsin inhibitor (Sigma-Aldrich) was used to quench trypsin activity during cell passage.
+ Open protocol
+ Expand
4

Cell Culture Protocols for Human Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CP-A (KR-42421), CP-B (CP-52731) and CP-C (CP-94251) cells (American Type Culture Collection) were cultured in MCDB-153 medium (Sigma, catalog no. M7403) supplemented with 0.4 μg/ml hydrocortisone, 20 ng/ml recombinant human Epidermal Growth Factor (Sigma, catalog no. E9644), 8.4 μg/L cholera toxin (Sigma, catalog no. H0135), 20 mg/L adenine (Sigma, catalog no. A2786), 140 μg/ml bovine pituitary extract (Sigma, catalog no. P1476), ITS Supplement (Sigma, catalog no. I1884, final concentrations: 5 μg/ml insulin, 5 μg/ml transferrin, 5 ng/ml sodium selenite), 4 mM glutamine and 5% fetal bovine serum. EPC2- hTert cells (20 (link)) were cultured in Keratinocyte-SFM medium (Gibco) supplemented with bovine pituitary extract and recombinant human Epidermal Growth Factor (Gibco). Soybean trypsin inhibitor (Sigma) was used to quench trypsin activity during cell passage.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!